Back to Search
MEHMET AKTAS, MD
MD
Clinical Cardiac Electrophysiology Physician
NPI: 1689680498IndividualAccepts Medicare
Specialties, Licenses & Credentials
Cardiovascular Disease Physician
Internal Medicine — Cardiovascular Disease
Code: 207RC0000X
238896(NY)
Clinical Cardiac Electrophysiology PhysicianPrimary
Internal Medicine — Clinical Cardiac Electrophysiology
Code: 207RC0001X
238896(NY)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Additional
CARDIAC ELECTROPHYSIOLOGYINTERNAL MEDICINE
Education
STATE UNIVERSITY OF NY UPSTATE MEDICAL UNIVERSITY
Class of 2002
Clinical Trials (1)
1
Linked Trials
0
Recruiting
1
With Results
Research & Publications (20)
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
PMID 32865377·N Engl J Med·2020
4-observational
Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.
PMID 31983236·Circulation·2020
8-other
Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.
PMID 30874754·JAMA·2019
4-observational
Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System.
PMID 30717173·Int J Mol Sci·2019
6-review
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart.
PMID 30710997·Cardiovasc Diabetol·2019
7-preclinical
Potential Mechanisms of Sodium-Glucose Co-Transporter 2 Inhibitor-Related Cardiovascular Benefits.
PMID 31741439·Am J Cardiol·2019
6-review
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
PMID 30415602·N Engl J Med·2019
4-observational
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
PMID 31535829·N Engl J Med·2019
3-trial
Contemporary Procedural Complications, Hospitalizations, and Emergency Visits After Catheter Ablation for Atrial Fibrillation.
PMID 29331355·Am J Cardiol·2018
4-observational
Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: The potential contribution to diabetes complications and cardiovascular disease.
PMID 30266577·Diabetes Metab·2018
6-review
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL.
PMID 29852973·J Am Coll Cardiol·2018
4-observational
Continuous monitoring after atrial fibrillation ablation: the LINQ AF study.
PMID 29688326·Europace·2018
4-observational
Atrial Fibrillation Burden: Moving Beyond Atrial Fibrillation as a Binary Entity: A Scientific Statement From the American Heart Association.
PMID 29661944·Circulation·2018
6-review
The anti-diabetic drug dapagliflozin induces vasodilation via activation of PKG and Kv channels.
PMID 29409796·Life Sci·2018
7-preclinical
The effect of dapagliflozin treatment on epicardial adipose tissue volume.
PMID 29301516·Cardiovasc Diabetol·2018
8-other
Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts.
PMID 28132924·Free Radic Biol Med·2017
7-preclinical
Catheter Ablation for Cardiac Arrhythmias: Utilization and In-Hospital Complications, 2000 to 2013.
PMID 29759619·JACC Clin Electrophysiol·2017
4-observational
Emergency Department, Hospital Inpatient, and Mortality Burden of Atrial Fibrillation in the United States, 2006 to 2014.
PMID 28964382·Am J Cardiol·2017
4-observational
Association between oxidative stress and atrial fibrillation.
PMID 28757307·Heart Rhythm·2017
4-observational
Methods, accuracy and clinical implications of atrial fibrillation detection by cardiac implantable electronic devices.
PMID 28143653·Int J Cardiol·2017
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 601 ELMWOOD AVE
ROCHESTER, NY 14642 - Phone
- (585) 275-4775
Quick Facts
- NPI
- 1689680498
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 24
- Clinical Trials
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile